Eupraxia Pharmaceuticals (EPRX) Common Equity (2022 - 2026)
Eupraxia Pharmaceuticals' Common Equity came in at $129.67 million for Q2 2026, up 518.2% from $20.98 million a year earlier but down 4.8% from the prior quarter.
Powered by 
Analysis
Eupraxia Pharmaceuticals (EPRX) Common Equity (2022 - 2026) Analysis & Trends
At the end of FY2025, Eupraxia Pharmaceuticals' Common Equity was $82.04 million, up 145.6% from FY2024.
- Common Equity carries a three-year compound annual growth rate of 124.9% (FY2022 to FY2025).
- Going back by year, Common Equity was $33.4 million in FY2024, $892,326 in FY2023 (-87.6%) and $7.21 million in FY2022.
- The five-year range for quarterly Common Equity is $892,326 (Q4 2023) to $136.19 million (Q1 2026).
- Year-over-year, Common Equity has increased for three consecutive quarters, with growth averaging 234.8% over the last five quarters.
- Business Quant data shows EPRX's Common Equity at $136.19 million (Q1 2026), $82.04 million (Q4 2025) and $88.44 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 40.27 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -4.58 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 44.95 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 51.81 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 14.35 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 89.30 Bn |
| 10 | Eupraxia Pharmaceuticals | 304.87 Mn | -174.66 Mn | - | 121.05 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 121.05 Mn |
| Jun 30, 2026 | 129.67 Mn |
| Mar 31, 2026 | 136.19 Mn |
| Dec 31, 2025 | 82.04 Mn |
| Sep 30, 2025 | 88.44 Mn |
| Jun 30, 2025 | 20.98 Mn |
| Mar 31, 2025 | 27.03 Mn |
| Dec 31, 2024 | 33.40 Mn |
| Sep 30, 2024 | 7.98 Mn |
| Jun 30, 2024 | 13.34 Mn |
| Mar 31, 2024 | 18.11 Mn |
| Dec 31, 2023 | 892,326.00 |
| Dec 31, 2022 | 7.21 Mn |
API Access
Eupraxia Pharmaceuticals Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=EPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "EPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=EPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();